The best boswellia to take is a Boswellia serrata extract standardized to contain at least 30% AKBA (acetyl-keto-boswellic acid), the compound most responsible for its anti-inflammatory effects. But the species, the extract formulation, and even how you take it all influence whether you get meaningful results. Here’s what actually matters when choosing a boswellia supplement.
Why AKBA Content Is What Matters Most
Boswellia resin contains dozens of active compounds, but boswellic acids are the ones that reduce inflammation. Among those, AKBA is the most potent. It works by blocking an enzyme called 5-lipoxygenase, which your body uses to produce inflammatory molecules. AKBA does this through a highly selective, non-competitive mechanism, meaning it binds to a specific site on the enzyme rather than competing with other molecules. The result is a targeted reduction in one of the key pathways that drives joint pain, swelling, and stiffness.
Not all boswellia extracts contain enough AKBA to be useful. Raw resin or low-grade extracts may contain only 2 to 3% AKBA. High-quality therapeutic extracts are standardized to 30% AKBA and 50 to 55% total boswellic acids. That standardization is what separates a supplement that works from one that doesn’t. When reading labels, look for the AKBA percentage specifically, not just “boswellic acids” as a generic claim.
Boswellia Serrata vs. Other Species
Several Boswellia species produce frankincense resin: Boswellia sacra from southern Arabia, Boswellia carterii from Somalia, and Boswellia frereana, also Somalian. You’ll see these names on essential oil products and some supplements. However, nearly all the clinical research on joint pain and inflammation has been done using Boswellia serrata, the Indian species sometimes called Indian frankincense or salai guggul.
The chemical profiles of these species differ, and there isn’t reliable diagnostic testing to distinguish between resins on store shelves. If your goal is anti-inflammatory support backed by human trials, Boswellia serrata is the species with the evidence behind it. Other species may have therapeutic potential, but the data simply isn’t there yet.
Patented Formulations Worth Knowing
Three branded Boswellia serrata extracts show up frequently in supplements, and they’re not interchangeable.
- 5-Loxin: An early standardized extract enriched for AKBA. In clinical trials on knee osteoarthritis, it reduced pain scores by about 8% within the first week at 100 mg per day, with continued improvement over 90 days.
- Aflapin (also marketed as ApresFlex): A newer formulation designed for better absorption. Head-to-head testing showed Aflapin delivered superior AKBA bioavailability compared to 5-Loxin. At the same 100 mg daily dose, it reduced pain by nearly 13% within seven days and showed greater improvements in stiffness (over 18% reduction in the first week). It works at a lower total dose because more of the active compound reaches your bloodstream.
- Boswellin Super: Standardized to 30% AKBA and 50 to 55% total boswellic acids. A placebo-controlled trial found it improved joint health and mobility in adults with early-stage osteoarthritis, with some participants noticing differences within five days.
If you’re comparing supplements, checking for one of these branded extracts on the label gives you more confidence in what you’re actually getting. Generic “boswellia extract” without a standardization claim is a gamble.
How Quickly Boswellia Works
Boswellia isn’t an overnight fix, but it’s faster than many people expect. Clinical trials consistently show measurable pain reduction within the first seven days. In one study on knee osteoarthritis, both tested formulations produced statistically significant improvements in pain, stiffness, and physical function after just one week of daily use, and those improvements continued building over 90 days.
A separate trial on exercise-induced soreness found that ten days of supplementation with a standardized extract reduced both muscle soreness and knee joint pain after intense downhill running. By day ten, the supplement group reported significantly lower soreness scores and had recovered enough leg strength to return to their pre-exercise baseline, while the placebo group had not.
The pattern across studies is consistent: expect some improvement in the first one to two weeks, with the full effect developing over two to three months of daily use.
Dosage for Different Conditions
The dose depends on what you’re taking it for and which extract you’re using. For high-AKBA formulations like Aflapin or ApresFlex, 100 mg per day has proven effective in clinical trials for osteoarthritis. For standard boswellia extracts (those with lower AKBA concentrations), the typical range is 300 to 500 mg taken two or three times daily.
For osteoarthritis specifically, clinical dosing has centered around 333 mg of extract three times per day with standard formulations. Inflammatory bowel conditions like ulcerative colitis have used 350 mg three times daily of a gum resin preparation. Rheumatoid arthritis protocols have gone higher, up to 3,600 mg per day, reflecting the greater inflammatory burden involved.
The key point: a 100 mg capsule of a high-bioavailability extract can outperform a 1,000 mg capsule of generic extract. Dose and formulation work together.
Take It With a Fatty Meal
Boswellic acids are fat-soluble, and this has a dramatic effect on absorption. A study measuring blood levels of boswellic acids after oral dosing found that taking the extract with a high-fat meal produced several-fold higher concentrations in the blood compared to taking it on an empty stomach. Two of the active boswellic acids were completely undetectable in the blood when taken without food but showed measurable levels when taken with fat.
This is one of the simplest ways to get more out of any boswellia supplement. Take it alongside a meal that contains some fat: eggs, avocado, nuts, olive oil, or even full-fat yogurt. Some formulations use lipid-based delivery systems designed to bypass this requirement, but unless the label specifically states enhanced bioavailability, assume you need food.
Safety and Medication Interactions
Boswellia has a generally strong safety profile in clinical trials, with most studies reporting mild or no side effects. However, it does interact with certain medications. Boswellic acids can inhibit some liver enzymes involved in drug metabolism and affect transport proteins that influence how medications move through your body.
Two case reports have documented elevated blood-thinning effects in people taking warfarin alongside boswellia, likely through these enzyme interactions. There are also caution flags for immunosuppressant drugs like cyclosporine and tacrolimus, where boswellia could alter drug levels in unpredictable ways. If you take blood thinners or immunosuppressants, this is a supplement to discuss with your prescriber before starting.
What to Look for on the Label
When choosing a boswellia supplement, prioritize these specifics in order of importance:
- Species: Boswellia serrata, not an unnamed “boswellia” or a different species.
- AKBA percentage: At least 20%, ideally 30% or higher. Avoid products that list only “total boswellic acids” without specifying AKBA content.
- Branded extract: Aflapin/ApresFlex, Boswellin Super, or 5-Loxin provide the most reliable standardization and have direct clinical trial support.
- Dose per serving: For high-AKBA extracts, 100 to 250 mg is sufficient. For standard extracts, you need 900 to 1,500 mg daily split across two or three doses.
- Third-party testing: A USP, NSF, or ConsumerLab seal confirms that what’s on the label matches what’s in the capsule.
A supplement hitting all five of these criteria will outperform the vast majority of boswellia products on the market, most of which use uncharacterized extracts at doses too low to produce meaningful results.